Abvc Biopharma, Inc. (ABVC)

CIK 1173313 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Abvc Biopharma, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 2026PRER14A0001213900-26-099293
Aug 27, 20268-K0001213900-26-094152
Aug 25, 2026PRER14A0001213900-26-093538
Aug 17, 2026424B40001213900-26-090775
Aug 17, 2026424B40001213900-26-090779
Aug 17, 2026424B40001213900-26-090777
Aug 17, 2026424B40001213900-26-090778
Aug 12, 202610-Q0001213900-26-088348
Aug 12, 20268-K/A0001213900-26-088165
Aug 12, 2026PRER14A0001213900-26-088445
Aug 4, 20268-K0001213900-26-084846
Jul 28, 2026PRE 14A0001213900-26-082298
Jul 2, 20268-K0001213900-26-074949
May 18, 202610-Q0001213900-26-058104
May 15, 2026NT 10-Q0001213900-26-057917
Mar 27, 20268-K0001213900-26-035499
Mar 27, 2026POS AM0001213900-26-035543
Mar 5, 2026DEF 14A0001213900-26-024122
Mar 3, 202610-Q/A0001213900-26-023062
Mar 3, 20268-K0001213900-26-023054
Mar 3, 202610-K0001213900-26-023063
Feb 5, 2026PRE 14A0001213900-26-012888
Jan 16, 20268-K/A0001213900-26-005165
Nov 14, 2025424B40001213900-25-110903
Nov 14, 2025424B40001213900-25-110902